OkuStim
Winner
Excellence in Business to Business
Medical Technologies
Details
Therapy begins where people retain control. For people affected by degenerative retinal diseases such as retinitis pigmentosa, treatment options are limited. OkuStim 2 sets a new benchmark: the CE-marked medical device enables the safe, precise and reliably reproducible independent use of transcorneal electrical stimulation. The headset integrates the stimulator with guided swivel units for accurate placement of filament electrodes. An electrode packaging designed as a guidance system supports intuitive magnetic application – design as a key driver of control, independence and therapy adherence.
The Jury‘s Statement
Many people with degenerative retinal diseases face the challenge of finding effective and self-determined therapy options. OkuStim 2 offers a groundbreaking solution that enables those affected to safely and precisely apply transcorneal electrical stimulation at home. The well-thought-out design of the headset combines functionality and user-friendliness by intuitively supporting the exact positioning of the electrodes, thereby promoting independence. This innovative approach facilitates regular therapy application and strengthens therapy adherence, which is crucial for improving quality of life. OkuStim 2 thus sets new standards in the treatment of retinitis pigmentosa and demonstrates how technical expertise and empathetic design can go hand in hand.
